Indeed, the loss of Col1a1 expression from tumor cells disrupts the structural and functional characteristics of oncostreams, resulting in a complete loss of mesenchymal areas within gliomas and a reduction in glioma malignant behavior (Fig. 10). Here, COL1A1 is linked to central nervous system cancer.